PRESCRIPTION PATTERN OF ANTI-HYPERTENSIVE MEDICATIONS IN PATIENTS WITH HYPERTENSION AT A TERTIARY CARE HOSPITAL, ASSAM
DOI:
https://doi.org/10.22159/ajpcr.2024v17i10.52069Keywords:
Antihypertensive, Hypertension, BP, Pattern of prescriptionAbstract
Objective: The aim of our study is to analyze the pattern of prescription of medications used for managing hypertension (HTN) at a tertiary care hospital and assess the comorbidities associated with HTN.
Methods: This prospective study has been conducted for duration of 6 months in the Department of Medicine of Silchar Medical College and Hospital. Prescriptions of both genders diagnosed with primary essential HTN and patients receiving or advised to start antihypertensive medications were included in the study.
Results: One hundred and fifty prescriptions have been evaluated in the study duration, 42% are female and 58% male. Monotherapy (69%) followed by dual therapy (26%) and multidrug therapy (5%) have been prescribed to the patients. Calcium channel blockers (CCBs) (48%) are the most widely used drugs, along with angiotensin receptor blockers (ARBs) (29%), beta-blockers (BBs) (11%), diuretics (6%), and angiotensin-converting enzyme inhibitors (6%) in single drug therapy. ARB+CCB followed by ARB+diuretic and ARB+BB were used in dual therapy. In triple therapy, the most preferred therapy was ARB+CCB+diuretic, and then ARB+CCB+BB. Dyslipidemia (38%), followed by Type 2 diabetes mellitus (DM) (34%), and chronic kidney disease (CKD) (19%) were the most common associated comorbidities.
Conclusion: Monotherapy was frequently prescribed regimen followed by dual therapy and multidrug therapy. In single-drug therapy, CCB was mostly used, and then ARB. In dual therapy CCB+ARB was the most preferred treatment. Dyslipidemia was most frequently associated with HTN, followed by DM and CKD. Prescription patterns of anti-hypertensive moderately followed the World Health Organization recommendations for HTN.
Downloads
References
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005 Jan 15-21;365(9455):217-23. doi: 10.1016/S0140- 6736(05)17741-1. PMid: 15652604
Gupta R, Gupta VP. Hypertension epidemiology in India: Lessons from Jaipur heart watch. Curr Sci. 2009;97(3):349-55.
Tasneem S, Vamsi Krishna E. Survey of prescription pattern of anti-hypertensive drugs in hypertensives and hypertension associated diabetics. Int J Pharma Bio Sci. 2010;1(4):23-6.
Mili J, Rao BS, Khan GM. Study of drug use in essential hypertension and their compliance. Kathmandu Univ J Sci Eng Technol. 2006;2(6):1-13, doi: 10.3126/kuset.v2i1.64222
Bansal SK, Saxena V, Kandpal SD, Gray WK, Walker RW, Goel D. The prevalence of hypertension and hypertension risk factors in a rural Indian community: A prospective door-to-door study. J Cardiovasc Dis Res. 2012 Apr;3(2):117-23. doi: 10.4103/0975-3583.95365, PMID: 22629029
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003 Dec;42(6):1206-52. doi: 10.1161/01. HYP.0000107251.49515.c2, PMid: 14656957
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20. doi: 10.1001/jama.2013.284427. Erratum in: JAMA. 2014 May 7;311(17):1809. PMid: 24352797
World Health Organization. Hypertension. World Health Organization; 2023 Mar 16. Available from: https://www.who.int/news-room/ fact-sheets/detail/hypertension#:~:text=hypertension%20is%20 diagnosed%20if%2c%20when,days%20is%20%e2%89%a590%20 mmhg [Last accessed on 2024 Apr 04].
Preethi GP, Jnaneshwara S, Narendranath S. Prescribing patterns of antihypertensive drugs in a South Indian tertiary care hospital. Drug Invent Today. 2011;3(4):38-40.
Jackson JH, Sobolski J, Krienke R, Wong KS, Frech-Tamas F, Nightengale B. Blood pressure control and pharmacotherapy patterns in the United States before and after the release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines. J Am Board Fam Med. 2008 Nov- Dec;21(6):512-21. doi: 10.3122/jabfm.2008.06.080025, PMid: 18988718
Gupta R, Prakash H, Gupta VP, Gupta KD. Prevalence and determinants of coronary heart disease in a rural population of India. J Clin Epidemiol. 1997 Feb;50(2):203-9. doi: 10.1016/s0895-4356(96)00281-8. PMid: 9120514
Pittrow D, Kirch W, Bramlage P, Lehnert H, Höfler M, Unger T, et al. Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol. 2004 Apr;60(2):135-42. doi: 10.1007/s00228-004-0731-6, PMid: 15042351
Tiwari H, Kumar A, Kulkarni SK. Prescription monitoring of anti-hypertensive drug utilisation at the Panjab University Health Centre in India. Singapore Med J. 2004 Mar;45(3):117-20. PMid: 15029413
Susheela SH, Narendranath S, Somashekar HS, Reshma SR, Keerthi SJ, Ramachandra K. Prescriptive pattern of antihypertensives in tertiary care hospital using DU-90%. Int J Pharm Res Dep. 2012;4(1):107-13. doi: 10.13040/IJPSR.0975-8232.3(6).1688-92
Pr R, Hv A, Shivamurthy M. Anti hypertensive prescribing patterns and cost analysis for primary hypertension: A retrospective study. J Clin Diagn Res. 2014 Sep;8(9):HC19-22. doi: 10.7860/ JCDR/2014/9567.4890, PMid: 25386458
Schmieder RE, Ruilope LM. Blood pressure control in patients with comorbidities. J Clin Hypertens (Greenwich). 2008 Aug;10(8):624-31. doi: 10.1111/j.1751-7176.2008.08172.x. PMid: 18772645
Chou CC, Lee MS, Ke CH, Chung MH. Prescription patterns of hypertension--National Health Insurance in Taiwan. J Chin Med Assoc. 2004 Mar;67(3):123-30. PMid: 15181964
Published
How to Cite
Issue
Section
Copyright (c) 2024 ARITRA GUPTA GUPTA, SARAJITA BARMAN, DOLLY ROY
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
